Protection against aflatoxin B1-induced hepatic toxicity as a short-term screen of cancer chemopreventive dithiolethiones

Fundamental and Applied Toxicology

Volumn 32, Issue 2, 1996, Pages 250-259

  Maxuitenko, Yulia Y ^a   Curphey, Thomas J ^a   Kensler, Thomas W ^b   Roebuck, B D ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DITHIOLE DERIVATIVE; AFLATOXIN B1; DITHIOL DERIVATIVE; LIVER ENZYME; PYRAZINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CANCER; CONTROLLED STUDY; DRUG SCREENING; HISTOCHEMISTRY; LIVER NECROSIS; LIVER TOXICITY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CHEMOPROPHYLAXIS; DRUG EFFECT; ENZYMOLOGY; FISCHER 344 RAT; LIVER; LIVER DISEASE; LIVER TUMOR; STRUCTURE ACTIVITY RELATION;

ANIMALIA;

AFLATOXIN B1; ANIMALS; CHEMOPREVENTION; LIVER; LIVER DISEASES; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PYRAZINES; RATS; RATS, INBRED F344; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030202559     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1996.0128     Document Type: Article

References (37)

1. Angsubhakorn, S., Poomvises, P., Romruen, K., and Newberne, P. M. (1981). Aflatoxicosis in horses. J. Am. Vet. Med. Assoc. 178, 274-278.
2. Ansher, S. S., Dolan, P., and Bueding, E. (1983). Chemoprotective effects of two dithiolethiones and of butylhydroxyanisole against carbon tetrachloride and acetaminophen toxicity. Hepatology 3, 932-935.
3. Ansher, S. S., Dolan, P., and Bueding, E. (1986). Biochemical effects of dithiolthiones. Food Chem. Toxicol. 25, 405-415.
4. Archer, S. (1985). The chemotherapy of schistosomiasis. Annu. Rev. Pharmacol. Toxicol. 25, 485-508.
5. Barreau, M., Cotrel, C., and Jeanmart, C. (1977). German Patent 2705641.
6. Benson, A. B., III. (1993). Oltipraz: A laboratory and clinical review. J. Cell. Biochem. Suppl. 17F, 278-291.
7. Bieri, J. G. (1980). Second report of the ad hoc committee on standards for nutritional studies. J. Nutr. 110, 1726.
8. Bolton, M. G., Muñoz, A., Jacobson, L. P., Groopman, J. D., Maxuitenko, Y. Y., Roebuck, B. D., and Kensler, T. W. (1993). Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis. Cancer Res. 53, 3499-3504.
9. Bueding, E., Dolan, P., and Leroy, J.-P. (1982). The antischistosomal activity of oltipraz. Res. Commun. Chem. Pathol. Pharmacol. 37, 293-303.
10. Cohen, S. M., and Ellwein, L. B. (1990). Cell proliferation in carcinogenesis. Science 249, 1007-1011.
11. Davies, M. H., Schamber, G. J., and Schnell, R. C. (1987). Role of glutathione in oltipraz-induced protection in acetaminophen and allyl alcohol hepatotoxicity in the male hamster. Toxicologist 7, 219.
12. De Long, M. J., Dolan, P., Santamaria, A. B., and Bueding, E. (1986). 1,2-Dithiol-3-thione analogs: Effects on NAD(P)H:quinone reductase and glutathione levels in murine hepatoma cells. Carcinogenesis 7, 977-980.
13. Egner, P. A., Kensler, T. W., Prestera, T., Talalay, P., Libby, A. H., Joyner, H. H., and Curphey, T. J. (1994). Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones. Carcinogenesis 15, 177-181.
14. Häusler, R., and Ritschard, J. (1979). Clinical study with a sialagogue drug (Sulfarlem S 25 = TTPT) in the treatment of xerostomia. Schweiz. Rundsch. Med. (Prax.) 68, 1063-1068.
15. Kaku, T., Ekem, J. K., Lindayen, C., Bailey, D. J., van Nostrand, A. W. P., and Farber, E. (1983). Comparison of formalin-and acetone-fixation for immunohistochemical detection of carcinoembryonic antigen (CEA) and keratin. Am. J. Clin. Pathol. 80, 806-815.
16. Kensler, T. W., Egner, P. A., Dolan, P. M., Groopman, J. D., and Roebuck, B. D. (1987). Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res. 47, 4271-4277.
17. 1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione. Carcinogenesis 6, 759-763.
18. Kensler, T. W., and Helzlsouer, K. J. (1995). Oltipraz: Clinical opportunities for cancer chemoprevention. J. Cell. Biochem. Suppl. 22, 101-107.
19. Kensler, T. W., Groopman, J. D., Eaton, D. L., Curphey, T. J., and Roebuck, B. D. (1992a). Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione. Carcinogenesis 13, 95-100.
20. Kensler, T. W., Groopman, J. D., and Roebuck, B. D. (1992b). Chemoprotection by oltipraz and other dithiolethiones. In Cancer Chemoprevention (L. Wattenberg, M. Lipkin, C. W. Boone, and G. J. Kelloff, Eds.), pp. 205-226. CRC Press, Boca Raton, FL.
21. Kensler, T., Styczynski, P., Groopman, J., Helzlsouer, K., Curphey, T., Maxuitenko, Y., and Roebuck, B. D. (1992c). Mechanisms of chemoprotection by oltipraz. J. Cell. Biochem. Suppl. 161, 167-172.
22. Kossor, D. C., Goldstein, R. S., Ngo, W., DeNicola, D. B., Leonard, T. B., Dulik, D. M., and Meunier, P. C. (1995). Biliary epithelial cell proliferation following α-naphthylisothiocyanate (ANIT) treatment: Relationship to bile duct obstruction. Fundam. Appl. Toxicol. 26, 51-62.
23. 1 in the rat. Toxicol. Appl. Pharmacol. 93, 442-451.
24. 1-induced preneoplastic foci in a rat model of hepatic tumorigenesis. Carcinogenesis 14, 2423-2425.
25. Meinetsberger, E., Schöffer, A., and Behringer, H. (1977). Eine einfache und ergiebige Herstellung von 3-Thioxo-1,2-dithiol (1,2-Trithion). Synthesis, 802-803.
26. Miller, D. M., Stuart, B. P., and Crowell, W. A. (1981). Experimental aflatoxicosis in swine: Morphological and clinical pathological results. Can. J. Comp. Med. 45, 343-351.
27. Newberne, P. M. (1973). Chronic aflatoxicosis. J. Am. Vet. Med. Assoc. 163, 1262-1269.
28. 1 in the dog. Path. Vet. 3, 331-340.
29. Prochaska, H. J., Chavan, S. J., Baron, P., and Polsky, B. (1995). Oltipraz, a novel inhibitor of human immunodeficiency virus type 1 (HIV-1) replication. J. Cell. Biochem. Suppl. 22, 117-125.
30. Prochaska, H. J., De Long, M. J., and Talalay, P. (1985). On the mechanism of induction of cancer protective enzymes: A unifying proposal. Proc. Natl. Acad. Sci. USA 82, 8232-8236.
31. Pugh, T. D., King, J. H., Koen, H., Nychka, D., Chover, J., Wahba, G., He, Y., and Goldfarb, S. (1983). Reliable stereological method for estimation the number of microscopic hepatocellular foci from their transections. Cancer Res. 43, 1261-1268.
32. Rao, C. V., Rivenson, A., Katiwalla, M., Kelloff, G. J., and Reddy, B. S. (1993). Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats. Cancer Res. 53, 2502-2506.
33. 1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): Predictive role for short-term molecular dosimetry. Cancer Res. 51, 5501-5506.
34. Roebuck, B. D., and Maxuitenko, Y. Y. (1994). Biochemical mechanisms and biological implications of the toxicity of aflatoxins as related to aflatoxin carcinogenesis. In The Toxicology of Aflatoxins: Human Health, Veterinary, and Agricultural Significance (D. L. Eaton and J. D. Groopman, Eds.), pp. 27-44. Academic Press, San Diego.
35. Solt, D., and Farber, E. (1976). New principle for the analysis of chemical carcinogenesis. Nature 263, 701-703.
36. Wattenberg, L. W., and Bueding, E. (1986). Inhibitory effects of 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) on carcinogenesis induced by benzo[a]pyrene, diethylnitrosamine and uracil mustard. Carcinogenesis 7, 1379-1381.
37. Wogan, G. N. (1976). The induction of liver cell cancer by chemicals. In Liver Cell Cancer (H. M. Cameron, D. A. Linsell, and G. P. Warwick, Eds.), pp. 121-152. Elsevier Scientific, Amsterdam/New York.